方法：对46例57眼手术治疗的NVG患者进行回顾性分析和随访，根据手术方式分Ahmed青光眼阀(AGV)植入术组(A组，24例31眼)和半导体二极管激光经巩膜睫状体光凝术(TSCPC)组(B组，22例26眼)，比较手术前后眼压、视力变化及术后并发症情况。

结果：两组术后眼压均较术前显著降低(P<0.05)，但组间无统计学差异(P>0.05)； 两组术后视力变化比较无统计学差异(P>0.05)； A组术后并发症明显低于B组，其中眼球疼痛、前房出血发生率比较有统计学差异(P<0.05)。

结论：AGV植入术与TSCPC治疗NVG均有效，但AGV植入术是滤过性手术，而TSCPC是睫状体破坏性手术，后者术后并发症更高。

METHODS: The clinical date of 46 cases(57 eyes)with NVG underwent surgical treatment were retrospectively analyzed and followed-up. Patients were divided into Ahmed glaucoma valve(AGV)implantation group(group A, 24 cases, 31 eyes)and semiconductor diode laser transscleral ciliary body photocoagulation(TSCPC)group(group B, 22cases, 26 eyes)according to the surgical approach. The intraocular pressure, visual acuity and postoperative complications were compared before and after operation.

RESULTS: The intraocular pressure postoperative in two groups were significantly lower than those preoperative(P < 0.05), but there was no significant difference between the two groups(P>0.05). The changes of visual acuity postoperative showed no statistical difference between the two groups(P>0.05). The postoperative complications of group A was significantly lower than that in group B, in which the incidence of eye pain, anterior chamber bleeding were significant differences between two groups(P <0.05).

CONCLUSION: AGV implantation treatment and TSCPC for NVG are both valid, but AGV implantation is filtration surgery, and TSCPC isciliary body destructive surgery, and the latter has higher rate of postoperative complications.